EBITDA Reconciliation Clause Samples

EBITDA Reconciliation. The following table shows reconciliations of net income, as reflected in the consolidated statements of operations, to EBITDA: Net income $84,652 $128,364 Provision/(credit) for federal income taxes 5,752 (5,230) Interest expense 13,168 22,607 Depreciation and amortization 42,483 34,354 EBITDA $146,055 $180,095 The following table presents information with respect to OSG's capital expenditures for the three months ended March 31, 2007 and 2006. Expenditures for vessels $57,673 $4,957 Investments in and advances to affiliated companies 25,869 - Payments for drydockings 7,838 8,619 Appendix 4 - 2007 TCE Rates The Company has achieved the following average estimated TCE rates for the percentage of days booked for vessels operating through April 13, 2007. The information is based, in part, on information provided by the pools or commercial joint ventures in which the vessels participate. All numbers provided are estimates and may be adjusted for a number of reasons, including the timing of any vessel acquisitions or disposals and the timing and length of drydocks and repairs. VLCC - Spot $63,500 610 936 1,546 39% Aframax - Spot $41,500 139 864 1,003 14% Aframax - Time $27,500 333 - 333 100% Panamax - Spot $29,000 51 327 378 13% Panamax - Time $26,500 523 - 523 100% Panamax - Time $19,000 178 - 178 100% Handysize - Spot $32,000 293 409 702 42% Handysize - Time $19,000 1,807 - 1,807 100% Product Carrier $39,000 413 133 546 76% ATB and Lightering Vessels $27,000 417 447 864 48%

EBITDA Reconciliation. The following table reconciles segment adjusted EBITDA to net income attributable to PAA (in millions): Segment adjusted EBITDA $ 2,081 $ 2,167 $ 2,212 Adjustments (1): Depreciation and amortization of unconsolidated entities (2) (45) (50) (45) Gains/(losses) from derivative activities net of inventory valuation adjustments (3) 46 (404) (110) Long-term inventory costing adjustments (4) 24 58 (99) Deficiencies under minimum volume commitments, net (5) (2) (46) — Equity-indexed compensation expense (6) (23) (33) (27) Net gain/(loss) on foreign currency revaluation (7) 26 (9) 29 Line 901 incident (8) (32) — (83) Significant acquisition-related expenses (9) (6) — — Depreciation and amortization (626) (494) (432) Interest expense, net (510) (467) (432) Other income/(expense), net (31) 33 (7) Income before tax 902 755 1,006 Income tax expense (44) (25) (100) Net income 858 730 906 Net income attributable to noncontrolling interests (2) (4) (3) Net income attributable to PAA $ 856 $ 726 $ 903

EBITDA Reconciliation. The following table reconciles Segment Adjusted EBITDA to Net income attributable to PAGP (in millions): Segment Adjusted EBITDA . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,230 $ 2,681 $2,081 Adjustments(1): Gains/(losses) from derivative activities net of inventory valuation adjustments(3) . . . . . . . . . . . . . . . . . . . . . . . . . . (160) 519 46 Long-term inventory costing adjustments(4) . . . . . . . . . . . . . . 20 (21) 24 Net gain/(loss) on foreign currency revaluation(7) . . . . . . . . . . (14) (3) 26 Unallocated general and administrative expenses . . . . . . . . . . . . (5) (4) (4) Depreciation and amortization . . . . . . . . . . . . . . . . . . . . . . . . (604) (521) (519)

EBITDA Reconciliation. Below is a reconciliation of Gentiva and Healthfield’s net income to adjusted EBITDA for the last twelve months ended September 30, 2005. The reconciliation is pro forma for the Merger, but not the financing transaction. ($ in millions) Gentiva Healthfield(1) Pro Forma Net income $ 23.9 $ 17.0 $ 40.9 Provision for income taxes 5.8 10.9 16.7 Interest (income) expense, net (1.7 ) 13.0 11.3 Depreciation and amortization 7.8 6.4 14.2 EBITDA (2) $ 35.8 $ 47.3 $ 83.1 Non-recurring expenses (0.3 ) 2.4 2.1 Adjusted EBITDA (2) $ 35.5 $ 49.7 $ 85.2 (1) Pro forma for a full twelve month contribution of Capital Health and certain other companies that were acquired during the period.